These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18625856)

  • 1. Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study.
    Steinerman JR; Irizarry M; Scarmeas N; Raju S; Brandt J; Albert M; Blacker D; Hyman B; Stern Y
    Arch Neurol; 2008 Jul; 65(7):906-12. PubMed ID: 18625856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The levels of water-soluble and triton-soluble Aβ are increased in Alzheimer's disease brain.
    McDonald JM; Cairns NJ; Taylor-Reinwald L; Holtzman D; Walsh DM
    Brain Res; 2012 Apr; 1450():138-47. PubMed ID: 22440675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.
    Kawarabayashi T; Younkin LH; Saido TC; Shoji M; Ashe KH; Younkin SG
    J Neurosci; 2001 Jan; 21(2):372-81. PubMed ID: 11160418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease.
    Tremblay C; Pilote M; Phivilay A; Emond V; Bennett DA; Calon F
    J Alzheimers Dis; 2007 Dec; 12(4):377-90. PubMed ID: 18198424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.
    Ikonomovic MD; Wecker L; Abrahamson EE; Wuu J; Counts SE; Ginsberg SD; Mufson EJ; Dekosky ST
    Arch Neurol; 2009 May; 66(5):646-51. PubMed ID: 19433665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice.
    Murphy MP; Beckett TL; Ding Q; Patel E; Markesbery WR; St Clair DK; LeVine H; Keller JN
    Neurobiol Dis; 2007 Sep; 27(3):301-11. PubMed ID: 17651976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
    Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease.
    Xia W; Yang T; Shankar G; Smith IM; Shen Y; Walsh DM; Selkoe DJ
    Arch Neurol; 2009 Feb; 66(2):190-9. PubMed ID: 19204155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease.
    Sandebring A; Welander H; Winblad B; Graff C; Tjernberg LO
    PLoS One; 2013; 8(2):e55847. PubMed ID: 23409063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
    Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
    Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA oxidation adducts 8-OHG and 8-OHA change with Aβ42 levels in late-stage Alzheimer's disease.
    Weidner AM; Bradley MA; Beckett TL; Niedowicz DM; Dowling AL; Matveev SV; LeVine H; Lovell MA; Murphy MP
    PLoS One; 2011; 6(9):e24930. PubMed ID: 21949792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry.
    Portelius E; Lashley T; Westerlund A; Persson R; Fox NC; Blennow K; Revesz T; Zetterberg H
    Neurodegener Dis; 2015; 15(1):50-7. PubMed ID: 25591542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenascin-C Is Associated with Cored Amyloid-β Plaques in Alzheimer Disease and Pathology Burdened Cognitively Normal Elderly.
    Mi Z; Halfter W; Abrahamson EE; Klunk WE; Mathis CA; Mufson EJ; Ikonomovic MD
    J Neuropathol Exp Neurol; 2016 Sep; 75(9):868-76. PubMed ID: 27444354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble amyloid beta levels are elevated in the white matter of Alzheimer's patients, independent of cortical plaque severity.
    Collins-Praino LE; Francis YI; Griffith EY; Wiegman AF; Urbach J; Lawton A; Honig LS; Cortes E; Vonsattel JP; Canoll PD; Goldman JE; Brickman AM
    Acta Neuropathol Commun; 2014 Aug; 2():83. PubMed ID: 25129614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.
    Cirrito JR; May PC; O'Dell MA; Taylor JW; Parsadanian M; Cramer JW; Audia JE; Nissen JS; Bales KR; Paul SM; DeMattos RB; Holtzman DM
    J Neurosci; 2003 Oct; 23(26):8844-53. PubMed ID: 14523085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrete Pools of Oligomeric Amyloid-β Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis.
    Chiang ACA; Fowler SW; Reddy R; Pletnikova O; Troncoso JC; Sherman MA; Lesne SE; Jankowsky JL
    Am J Pathol; 2018 Mar; 188(3):739-756. PubMed ID: 29248459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
    Villemagne VL; Rowe CC
    J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline.
    Parvathy S; Davies P; Haroutunian V; Purohit DP; Davis KL; Mohs RC; Park H; Moran TM; Chan JY; Buxbaum JD
    Arch Neurol; 2001 Dec; 58(12):2025-32. PubMed ID: 11735776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.